Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir vs Telbivudine to Prevent Mother-to-Infant HBV Transmission
ChiCTR-OPC-16008331Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jan 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir and telbivudine in Chronic Hepatitis B (CHB) (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: Serum markers for hepatitis B, HBV DNA level and 3 more. Started Jan 2015; status: recruiting.
02
Drugs
tenofovirtelbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPC-16008331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008331.